A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Megestrol Acetate 160Mg Tablet|DRUG: Anastrozole 1Mg Tablet|DRUG: Letrozole 2.5Mg Tablet|DRUG: Exemestane 25 MG|DRUG: Tamoxifen 20Mg Tablet|DRUG: Fulvestrant 50Mg Solution for Injection
Sponsor: Instituto Nacional de Cancer, Brazil
Collaborators: Cancer Research UK Cambridge Institute